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able influence of pacing with a short AV delay in congestive heart 
failure (Z-4). 
Auwchio and Klein have raised several iwcs regarding our study 
population, and data interpretation. To evaluate the independent 
effects of pacing objectively, we enrolled only patients with stable 
medical regimens. However, they were severely ill, as indicated by 
marked symptoms despite optimixed medical therapy and a mean left 
ventricular ejeetiin fraction of 20%. Patients with acute onset of 
congestive heart failure and those requiring intravenous inotropic 
therapy were specitkally excluded &cause of the improvement often 
observed after the initial presentation and treatment of congestive 
heart failure and the possible persistent benefit after a course of 
inotmpic therapy. Such findings would confound the interpretation of 
any changes observed with pacing and mmt likely mntnited to the 
apparent benefit reported in previous uncontrolled studies. The 
objection to including patients with both ischemie and dilated cardio- 
myopathy is unclear because Auricchi and Klein cite studies that 
report the benefit of short AV delay pacing in both groups. Of note, we 
fouti no differences in msponse between these groups. All patients 
with ischemic cardiomvopathy had tmtltiveessel coronary artery disease 
with no evidence of active ischemia, such as unstable angina ot recent 
myocardial iufaretion. Diabetes mellitus was present in one patient. 
and four patients had chronic obstructive pulmonary disease. 
The data from eight patients with a serial evaluation of left 
ventricular ejeetii fraction during long-tetm pacing were presented. 
As stated in the text, nine patients completed this phase of the study, 
but left ventricuhu ejeetii fraction data from one patient were 
exduded because he developed atrial fibrillation during VDD pacing, 
with worsening congestive heart failure. We strongly disagree that an 
increase in left ventriadar ejection fraction from 22% to 26% in a 
single patient is evidence of improvement in a subgroup. This change 
is within the gene.raUy accepted measurement variability (5%) of 
radionudide ventrieulography, and thii patient showed uo evidence of 
clfnicaf improvement. Moreover, other patients showed a larger de- 
crease in left venttiadar ejeetiin fraction with dual chamber pacing 
(e.g., 20% to HI%), but again this was not dii as a possible 
deleterious effect of pacing because there is no basis to isolate this 
finding. The reason to perfotm contmBed studies is to avoid basii 
mnchsions on anecdotal observations or measurement variability. As 
such, our results dearly demonstrate no effect of pacing on left 
ventricular ejection tktiou, clinical status, body weight, blood pres- 
sure, heart late or diuretic usage in this patient population 
Concern was raked regarding the methodology for assessment of 
the acute hemodynamic effects of pacing. The order of pacing was 
varied and baseline measurements were performed both berore and 
alter pacing, demonstrating the lack of hemodynamii drift or cumu- 
lative effects of the intirsiin of small volumes of dextrose and *ater. 
The blhded study design avoided any inapparent biases in data 
interpretation. Finally, the hemodynamk protocol used is well es& 
liied and can de&t henmdymic changes when an intervention has 
an elfect ($6). 
lnsummaty,ourdatasupporttheamclusionthatthemutineuse 
of pacemakers as primary tmatment for patients with comgesdve heart 
bihueistmwarmntedWedhagreewithAuric&oandRkmthat 
pacing is a “cheap therapy,” No invasive procedure utilixing sophii- 
cated implanted devices is cheap, pmiilarly if it is of no bet&t. We 
do antatr, however, that further study b warmuted to evaluate paeittg 
iItthiaseailtgandhavepmpnaedseveralaltemativepadng~ 
(1,7). Howwer, this reEearcb mf&l he pmqeak, CQntrolled aEd 
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hypothesis driven and not anecdotal or retrospective Idanalyses of 
data. 
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Diagnosis and Management of Fetal 
Cardiac Tumors 
1 would lie to challenge the conduskns of H&y et al. (1). lltey 
present19cilsesoffetalcardiacrumorandconctudethattbq~ 
“often benign.” However. >SO% were -ted with tuberose sde- 
m&s. If tuberose sderosis is present, -67% of tbesc children wiu be 
handicapped, 50% them profoundly. This ic hardly a “be&u” out- 
come. 
Twospontaueousdeathsoonuredintheremainiiniuepatknts 
A22~mortalibr;lteisnotwrybea~.InmypeMoal~of 
14casesoffelaloldiachMor(11reported[2]),therehavebLeo6ve 
span- death (35% mortality rate). 
fnaddikm,Iamtmtomvimedthattuberoseselerosbwas 
exdudedintheremaiuhtgninepatietus.Tberewasonespontaneous 
intrauteri5e death and cute termination of pmgnattcy, but the cranial 
lesiousoftuberosesdermisareootusuaUy deiembkinthefetuseven 
ifautopsywasperformediuthesetwocasea.Oftheseventemair@ 
fehlsesthcrearewdetsilrastothele~aavthodcf~~. 
Overa8foBow-upwasbetweett1we&and8yeors,buthis 
toexcbtdetuhemsesdemsiscate8orUtyittthefirstyearofRfe.In 
additioqthereisnoindi&mastohQltborougblytubwraesderosis 
wasmughtiinsQmecasesbthcompgtedtomog;rphyaad~ 
resmaweim3gingarewxsarytomaketbisdiag@sInntyseriq 
6veof&xittfatssun%ugtobirthhadtubemsssdemG,twodsir 
wiCtsingfetumors.Img8cattlmtitislikefythattlwaeweremorecases 
iJl1heseriesofHoueyetal.withtu&mmesclemsisthantbe~~ 
itledbi 
1.350 LElTERS l-0 THE ELXTOR 
7be authors may mean that a single cardiac tumor may be benign 
and mmssociated with tubetose sclerosis or that tumors may be 
cardiity benign because most tumors regressed spontaneously 
or did not require treatment, but they do not say that. Their conclusion 
is therefore misleading and inappropriate. 
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cardiac tumor wbo may not develop tuberous sciemsis is an equally 
significant event. 
Assessing the Significance of 
Preinfarction Angina 
With regard to the letter by Aban concerning the conclusions of our 
report (1). I do not feel that our conciustons arc misleading or 
inapprotniate; rather, Atlan has simply misinterpreted our intended 
context of the word “benign.” 
This huge, retmspective, multiu‘nter study was intended to provide 
epidemio~c information about the disgnosis and management of 
fetal cardii trmmrs. Given the retrospective nature of the study. II I 
not surprisii Atlan notes that some data were not available rar each 
case. Despite these timitations, which were addressed in the di;cuGxt, 
the proportion of fetal patients with tubemus sclerosis and fetal 
tumors was similar to that reported in other peliatric studii (50%). 
The term “benign” was used twice in our report, once in the 
abstract and once in the discussion. In the abstract the contest of the 
word “beatii” refets to tissue type of tumors of 19 tumors discev- 
ered, 17 were rhabdomycenas, a benign tumor. The other IWO tumors 
were not benign-a tibroma that infiltrated throughout much of the 
heart and an atrial hemangioma. In thin mntext, “benign” is neither 
misbding nor &mate. 
In the d&usGn, ?senign” does indeed, and was intended to, refer 
tooutcome. 1 have no prmblem in stating that fetal cardiac tumors “can 
behave in a benign fash&” Not all rumors required intervention; 
some tumors spontaneo4y involuted; and not all patients with tumors 
had tthmus schosis (as in Abn’s personal experience). In fa& as 
Alian 00% out data suggesl that sin& ttmsors are rarety associated 
with tttberotts sderosis; a tinding ditferent from that reported previ- 
o&y (2). This point is further daritied in the tinat sentence of the 
report, which states “therefore, counseTmg of families where singte 
cardiac~ispresentmaybemoreoptimist.ic.” 
I am all tou concerned that physickms performing fetal echocardi- 
onthebasisofanincompleteknowl- 
the published reports. This goint was 
pt+n& made in an editorial by H&a (3). Our multicenter study 
also higftliib the imptam. of completing our knowiedge base of 
fetal diseas before recommending thempies as signi6cant as fetal 
tionofpKgnanq.Thereisnodo~rutattuberous 
a dewastatmg effed on chiien and their famitii 
~~t~~ofa~~~a~~~~asi~ 
Tbc report by Anrai et al. (I) in a recent tssue of tbe Journal concluded 
that patients with ;xeinfarction angina pectoris have a more favorable 
short- and long-term prognosis after hospital admission for acute 
myocardial infarction. This is in contrast to previous studies eaamining 
the issue, which have found that patients with a history of angina 
actually have a worse short- and long-term pmgncsis after a myocar- 
dial infarction (Z-5). As poinicd out in the report by Anzai et al., the 
majority of previous studies did not control for confounding variables. 
such as prior myocardial infarction, severity of coronary disease, signs 
of heart failure and infarction location. In an attempt to overcome 
these limitations, Anmi et al. (1) limited their study population to 
patients without a history of prior infarction and controlled for 
mrmemus confounding variables The authors concluded that 1) prein- 
farction angina is an independent predictor of decreased in-hospital 
mortality, and 2) in patients with an acute anterior infarction, preinfarc- 
tion angina is asxciated with a lauer incidence of cudii rupture, 
ventriadar aneurysm formation and readmiiion for heart failure. They 
hypothesized that tbe benebcial effect of preinfarction angina occurred 
from infarct she limitation passibb secondary to ischcmic preconditioning 
(1). 
Although the patients with and those without a history of angina 
appeared to be we1 matched with respect to age, gender and cardiac 
risk factors, an alternative exptanation for the beneficial effects of 
-gina observed in this study is that preinfarction angisa is a marker 
for a confounding factor that w&s not measured. such as aspirin use. 
The investigators controlled for numerous mediitions, including the 
use of thrombotybk therapy, beta-adrenergic blocking agents, calcium 
antagonists and angiotensin-converting enzyme inhibitors but surpris- 
ingly failed to control for aspirin use. It is quite plausibte that patients 
who developed angina before their first myocardial iofarciion were 
more likely to be taking aspirin. 
In a recent study, Garcia-Dorado et al. (6) prospectively evaluated 
the et&t of previous aspirin use in patients prese .ing with acute 
ischemic syndromes. Tbey found that previous aspirin use was asaoci- 
atedwithashattwvardalesssevereclinical~aodthatinthe 
subset of patients wbo devetoped a myocardial infarction, prior aspirin 
tse was amcxiated with a 38% reduction in peak ueatine kinase (CX). 
